Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nelson

Showing results (291-300 of 310) with videos related to

Pageof 31
Sort By:
Heart, Lung & Circulation|August 26, 2020
Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in AustraliaRachel E Climie, Jason H Y Wu, Anna C Calkin, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 29, 2025
Co-Design of a Registry-Based Tailored Follow-up Service Intervention for People Living With Stroke: A Multiple Method Consensus ApproachTara Purvis, Andrew G Ross, Jannette M Blennerhassett, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Pageof 31

Showing results (291-300 of 310) with videos related to

Sort By:
Pageof 31
Heart, Lung & Circulation|August 26, 2020
Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in AustraliaRachel E Climie, Jason H Y Wu, Anna C Calkin, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|October 29, 2025
Co-Design of a Registry-Based Tailored Follow-up Service Intervention for People Living With Stroke: A Multiple Method Consensus ApproachTara Purvis, Andrew G Ross, Jannette M Blennerhassett, et al.
Kidney International|September 13, 2020
Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney diseaseRory Wolfe, James B Wetmore, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Pageof 31